Manual blood exchange transfusion does not significantly contribute to parasite clearance in artesunate-treated individuals with imported severe Plasmodium falciparum malaria

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Kreeftmeijer Vegter, Annemarie R ^a,b   Melo, Mariana De Mendonça ^c   De Vries, Peter J ^a,d   Koelewijn, Rob ^c   Van Hellemond, Jaap J ^c,e   Van Genderen, Perry J J ^c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ACE Pharmaceuticals BV   (Netherlands)

^c Harbour Hospital   (Netherlands)

^d Tergooi Hospitals   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; MALACEF 60; QUININE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD VOLUME; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; EXCHANGE BLOOD TRANSFUSION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MANUAL BLOOD EXCHANGE TRANSFUSION; PARASITE CLEARANCE; PLASMODIUM FALCIPARUM; RETROSPECTIVE STUDY; WORLD HEALTH ORGANIZATION;

ADULT; ANIMALS; ANTIMALARIALS; ARTEMISININS; BLOOD; EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; NETHERLANDS; PLASMODIUM FALCIPARUM; QUININE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84875322154     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-115     Document Type: Article

References (31)

1. WHO, Guidelines for the treatment of malaria Geneva: World Health Organization 2010
2. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Dondorp A, Nosten F, Stepniewska K, Day N, White N, Lancet 2005 366 717 725
3. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, Bojang K, Olaosebikan R, Anunobi N, Maitland K, Kivaya E, Agbenyega T, Nguah SB, Evans J, Gesase S, Kahabuka C, Mtove G, Nadjm B, Deen J, Mwanga-Amumpaire J, Nansumba M, Karema C, Umulisa N, Uwimana A, Mokuolu OA, Adedoyin OT, Johnson WB, Tshefu AK, Onyamboko MA, Sakulthaew T, Ngum WP, Silamut K, Stepniewska K, Woodrow CJ, Bethell D, Wills B, Oneko M, Peto TE, Day NP, White NJ, von SL, Lancet 2010 376 1647 1657
4. Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium. Kreeftmeijer-Vegter AR, van Genderen PJ, Visser LG, Bierman WF, Clerinx J, van Veldhuizen CK, de Vries PJ, Malar J 2012 11 102
5. Treatment of imported severe malaria with artesunate instead of quinine-more evidence needed? Cramer JP, Lopez-Velez R, Burchard GD, Grobusch MP, de Vries PJ, Malar J 2011 10 256
6. Severe imported falciparum malaria: a cohort study in 400 critically ill adults. Bruneel F, Tubach F, Corne P, Megarbane B, Mira JP, Peytel E, Camus C, Schortgen F, Azoulay E, Cohen Y, Georges H, Meybeck A, Hyvernat H, Trouillet JL, Frenoy E, Nicolet L, Roy C, Durand R, Le Bras J, Wolff M, Severe imported malaria in Adults (SIMA) Study Group, PLoS One 2010 5 13236
7. Exchange transfusion as an adjunct to the treatment of severe falciparum malaria: case report and review. Phillips P, Nantel S, Benny WB, Rev Infect Dis 1990 12 1100 1108
8. Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis. Riddle MS, Jackson JL, Sanders JW, Blazes DL, Clin Infect Dis 2002 34 1192 1198
9. Severe falciparum malaria: survival without exchange transfusion. Marik PE, AmJTrop Med Hyg 1989 41 627 629
10. Exchange blood transfusion in severe falciparum malaria: retrospective evaluation of 61 patients treated with, compared to 63 patients treated without, exchange transfusion. Burchard GD, Kroger J, Knobloch J, Hartmann WJ, Eichenlaub D, Moling O, Fleischer K, Van den Ende J, Demey H, Weber R, Pichler H, Francioli P, Luthy R, Nothdurft HD, Weincke T, Schmutzhard E, Kretschmer H, Dietz K, Trop Med Int Health 1997 2 733 740
11. Exchange transfusion for malaria: what are the indications? Wallace MR, al Mahroos GM, Rev Infect Dis 1991 13 763 764
12. Treatment of severe malaria by exchange transfusion. Vachon F, Wolff M, Clair B, Regnier B, N Engl J Med 1990 322 58 59
13. Exchange transfusion as an adjunct to the treatment of severe falciparum malaria. Vachon F, Wolff M, Lebras J, Clin Infect Dis 1992 14 1269 1270
14. Hyperparasitemia and blood exchange transfusion for treatment of children with falciparum malaria. Mordmuller B, Kremsner PG, Clin Infect Dis 1998 26 850 852
15. Evaluation of plasma lactate as a parameter for disease severity on admission in travelers with Plasmodium falciparum malaria. van Genderen PJ, van der Meer IM, Consten J, Petit PL, van Gool T, Overbosch D, J Travel Med 2005 12 261 264
16. Efficacy and safety of exchange transfusion as an adjunct therapy for severe Plasmodium falciparum malaria in nonimmune travelers: a 10-year single-center experience with a standardized treatment protocol. van Genderen PJ, Hesselink DA, Bezemer JM, Wismans PJ, Overbosch D, Transfusion 2010 50 787 794
17. Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Flegg JA, Guerin PJ, White NJ, Stepniewska K, Malar J 2011 10 339
18. Combinations of artemisinin and quinine for uncomplicated falciparum malaria: efficacy and pharmacodynamics. De Vries PJ, Bich NN, Van TH, Hung LN, Anh TK, Kager PA, Heisterkamp SH, Antimicrob Agents Chemother 2000 44 1302 1308
19. Population pharmacokinetics II: estimation methods. Ette EI, Williams PJ, Ann Pharmacother 2004 38 1907 1915
20. Handling covariates in population pharmacokinetics. Mentre F, Mallet A, Int J Biomed Comput 1994 36 25 33
21. The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods. Sheiner LB, Drug Metab Rev 1984 15 153 171
22. Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model. Steimer JL, Mallet A, Golmard JL, Boisvieux JF, Drug Metab Rev 1984 15 265 292
23. Population pharmacokinetics I: background, concepts, and models. Ette EI, Williams PJ, Ann Pharmacother 2004 38 1702 1706
24. Artesunate versus quinine for treating severe malaria. Sinclair D, Donegan S, Isba R, Lalloo DG, Cochrane Database Syst Rev 2012 6 CD005967
25. No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali. Maiga AW, Fofana B, Sagara I, Dembele D, Dara A, Traore OB, Toure S, Sanogo K, Dama S, Sidibe B, Kone A, Thera MA, Plowe CV, Doumbo OK, Djimde AA, AmJTrop Med Hyg 2012 87 23 28
26. Artemisinin resistance in Plasmodium falciparum malaria. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ, N Engl J Med 2009 361 455 467
27. A current diagnostic and therapeutic problem. Gyr K, Speck B, Ritz R, Cornu P, Buckner CD, Cerebral tropical malaria with blackwater fever, Schweiz Med Wochenschr 1974 104 1628 1630
28. What is the future of exchange transfusion for falciparum malaria? Pasvol G, Jacobs M, J Infect 1999 39 183 184
29. Automated erythrocytapheresis in the treatment of severe falciparum malaria. Macallan DC, Pocock M, Bishop E, Bevan DH, Parker-Williams J, Harrison T, Robinson GT, J Infect 1999 39 233 236
30. Plasma exchange and severe Plasmodium falciparum malaria. Apropos of 2 cases. Bolandard F, Hommel D, Hulin A, Cah Anesthesiol 1995 43 371 373
31. The role of reduced red cell deformability in the pathogenesis of severe falciparum malaria and its restoration by blood transfusion. Dondorp AM, Nyanoti M, Kager PA, Mithwani S, Vreeken J, Marsh K, Trans R Soc Trop Med Hyg 2002 96 282 286